View More
What should our patients with NAFLD eat? Expert faculty explore the evidence behind different diets in NAFLD/NASH.
Rotonya Carr, MD
Raymond E. Soccio, MD, PhD
Released: November 7, 2019
Listen as expert hepatologist faculty explore the evidence behind different diets in NAFLD/NASH.
Rotonya Carr, MD
Released: November 25, 2019
Listen as expert endocrinologist faculty explore the evidence behind different diets in NAFLD/NASH.
Raymond E. Soccio, MD, PhD
Released: November 25, 2019
Explore the latest on NASH screening and the interplay between NAFLD, metabolic syndrome, CV risk, and diabetes risk.
Kenneth Cusi, MD, FACP, FACE
Brent A. Neuschwander-Tetri, MD
Released: November 22, 2019
Listen as expert hepatologist faculty explore NASH screening and interplay between NAFLD, metabolic syndrome, CV risk, diabetes risk.
Brent A. Neuschwander-Tetri, MD
Released: December 3, 2019
Listen as expert endocrinologist faculty explore NASH screening and interplay among NAFLD, metabolic syndrome, CV risk, diabetes risk.
Kenneth Cusi, MD, FACP, FACE
Released: December 5, 2019
Weigh the latest perspectives on wet biomarkers, imaging, and combination tests.
Rita Basu, MD
Stephen A. Harrison, MD, COL (Ret.), FAASLD
Released: December 6, 2019
Listen as expert hepatologist faculty weigh the latest perspectives on wet biomarkers, imaging, and combination tests.
Stephen A. Harrison, MD, COL (Ret.), FAASLD
Released: December 16, 2019
Listen as expert endocrinologist faculty weigh the latest perspectives on wet biomarkers, imaging, and combination tests.
Rita Basu, MD
Released: January 23, 2020
Learn the place of available approaches to managing NASH, including lifestyle and vitamin E, and compounds that target insulin resistance.
Juan Pablo Frias, MD, FACE
Philip N. Newsome, PhD, FRCPE
Released: December 13, 2019
Listen as expert hepatologist faculty discuss the place of available approaches to managing NASH, including lifestyle and vitamin E, and compounds that target insulin resistance.
Philip N. Newsome, PhD, FRCPE
Released: January 3, 2020
Listen as expert endocrinologist faculty discuss the place of available approaches to managing NASH, including lifestyle and vitamin E, and compounds that target insulin resistance.
Juan Pablo Frias, MD, FACE
Released: December 18, 2019
American Gastroenterological Association (AGA)
4930 Del Ray Avenue
Bethesda, MD 20814
Phone: (301) 654-2055
Fax: (301) 654-5920
Email: member@gastro.org
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.